Thymulin: the thymus hormone that fades by 60, and what research says about it

Thymulin is made only in the thymus, needs zinc to work, and falls below standard detection in most people by 60. What 50 years of research found, what zinc has to do with it, and why there is still no human trial of thymulin itself.

Published · Updated · 9 min read
TL;DR
  • Thymulin is a nine-amino-acid hormone made only by the thymus. It peaks in childhood, declines through adulthood, and is undetectable by standard bioassay in most people after 60.
  • Thymulin is active only when bound to zinc. Studies by Mocchegiani and colleagues found that some older adults with undetectable thymulin had the zinc-free, inactive form, and that correcting zinc deficiency restored some activity.
  • No controlled human trial has tested thymulin given as a peptide for immune ageing, and no human dose has been established.
  • Thymulin is not approved by the FDA for any use.
  • Genes such as HLA, IL6 and FOXO3 are linked to immune and ageing traits, but none has been tested against response to thymulin.

The thymus is the organ where T-cells, a central part of the immune system, are trained. It is largest in childhood and shrinks steadily through adulthood. Thymulin is one of the signals it makes, and its decline with age is one of the better-documented markers of that shrinking. This page covers what thymulin is, how it changes with age, why zinc matters, and how far the research has and has not gone. It is a summary of research, not a recommendation.

Age 60

The approximate age at which thymulin falls below what the standard bioassay can detect in most people, in studies measuring it across the lifespan.

Thymulin (also called FTS, from the French facteur thymique serique, or serum thymic factor) is a nine-amino-acid peptide made only by the epithelial cells lining the thymus. Jean-Francois Bach and Mireille Dardenne at the Institut Pasteur in Paris characterised it over two decades starting in the early 1970s, and the research has continued since.

In plain English

The thymus trains T-cells before they enter the bloodstream. Thymulin is one of the signals involved in that training. As the thymus shrinks with age, thymulin falls, and fewer new T-cells are trained. That shift is part of what immunologists call immunosenescence, the gradual change in immune function with age.

The Age Curve

How thymulin changes with age

A study listed in PubMed as "Distribution of age-related thymulin titres in normal subjects through the course of life" measured thymulin from newborns to older adults. Activity peaks in childhood, declines through the 20s and 30s as active thymic tissue is replaced by fat, and is undetectable by the standard test in most people after 60.

Age group Relative thymulin activity What is happening
Birth to age 6 Rising Thymus growing
Age 6 to 12 Peak Maximum thymic volume
Age 20 to 35 Declining Thymic involution begins; fat replaces active tissue
Age 40 to 55 Low but detectable Residual output
After age 60 Undetectable in most people The standard test finds no active thymulin; some inactive form may remain

"Undetectable" does not necessarily mean none is being made. The standard bioassay detects the active, zinc-bound form. Some peptide may still be circulating in its inactive form.

The progressive decline of serum thymulin with age parallels the involution of the thymus and constitutes one of the most reliable markers of thymic aging.

Review of Thymic Peptides and Hormones from Properties to Clinical Application, Springer, 2024

Why zinc matters to thymulin

Thymulin is biologically inactive without zinc. It circulates in two forms: active thymulin, bound to zinc, and apothymulin, without it. Only the zinc-bound form acts on T-cells.

Active thymulin (zinc-bound)

Acts on T-cell receptors and is involved in their maturation. This is the form the standard bioassay detects.

Apothymulin (zinc-free)

Inactive. Not detected by the standard bioassay. Present in some older adults who test at zero.

Zinc deficiency becomes more common with age. Eugenio Mocchegiani and colleagues at INRCA in Ancona, Italy studied older adults with undetectable active thymulin and found that correcting zinc deficiency partially restored measurable thymulin activity. Those people still had some thymulin in circulation, in its inactive form. The recovery was partial, not a return to youthful levels, and it applied to people who were zinc-deficient. Zinc status is something a clinician can measure.

What the decline is linked to

The thymus keeps producing some T-cells even after it shrinks, but fewer new ("naive") T-cells enter circulation, and those that do recognise a narrower range of threats. Research has linked this to the broader picture of immune ageing: more infections, slower recovery and changes in immune regulation.

90%

The estimated reduction in functional thymic tissue by age 70, from imaging studies of active thymic tissue versus fat replacement across age groups.

A 2024 Springer review of thymic peptide research described this pattern across clinical populations and noted thymulin's unusual position: well characterised for decades, with a clear biological role, but with no completed controlled human trials of supplementation. Preclinical work in 2018 also reported anti-inflammatory and pain-reducing effects of thymulin, showing that its receptors exist outside the thymus.

The Research Gap

What has and has not been tested

Zinc

The Mocchegiani studies are the main human evidence that thymulin activity can be partly recovered, and only in people who were zinc-deficient. They tested zinc, not thymulin.

Thymulin as a peptide

Thymulin is not approved by the FDA for any use. Its studied doses come from preclinical work and do not translate to people. No controlled human trial of thymulin for immune ageing has published outcome data.

Hair research

Thymulin receptors have been found on the cells at the base of hair follicles, and early research looked at thymulin and hair cycling. No controlled human trial has shown that zinc-thymulin formulations treat hair loss.

Genetics

Where genetics fits

Immune ageing varies between people of the same age, and some of that variation is inherited. HLA genes determine which fragments of germs and damaged cells T-cells can recognise. IL6 promoter variants are associated with higher baseline inflammation, which has been linked to faster thymic shrinking in research on immune ageing. Certain FOXO3 variants are more common in people who live past 100.

None of these has been tested against thymulin levels or against response to thymulin. A DNA report can show which versions you carry and what the research on them does show; it cannot tell anyone how they would respond to thymulin.

For the thymic peptide with far more human trial data, see thymosin alpha-1. For the pineal peptide from a related research tradition, see Epithalon and telomere length.

The short version: thymulin's decline with age is well documented, and its dependence on zinc is well established. In zinc-deficient older adults, correcting zinc partly restored thymulin activity. Thymulin given as a peptide has no completed human trial, no established human dose and no FDA approval, and no genotype has been tested against it.

ShareXLinkedIn
Your DNA reportSee how your DNA reads the peptides in this guide.Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show. Checked by our team, ready within 24 hours.Upload your DNA, $99No DNA test yet? Order one →

Frequently asked questions

What does thymulin do in the body?

Thymulin is a hormone made by the epithelial cells of the thymus. It is involved in the maturation of immature T-cells into functional immune cells. Preclinical research has also reported anti-inflammatory and pain-reducing effects, suggesting it acts outside the thymus as well.

Why does thymulin fall with age?

Thymulin is made only by the thymus, which shrinks from early adulthood as active tissue is replaced by fat. By about 60, most people have so little active thymic tissue that thymulin falls below what the standard bioassay can detect.

What is the link between zinc and thymulin?

Thymulin is active only when bound to zinc; without it, it circulates as inactive apothymulin, which the standard test does not detect. Studies by Mocchegiani and colleagues found that correcting zinc deficiency in older adults partly restored measurable thymulin activity. That finding applies to people who were zinc-deficient.

What is the difference between thymulin and thymosin alpha-1?

Thymulin acts inside the thymus on the maturation of T-cells. Thymosin alpha-1 is a 28-amino-acid peptide that acts on mature immune cells. Thymosin alpha-1 has about 30 completed controlled human trials and is approved in more than 35 countries for hepatitis B; thymulin has no completed controlled human trials for immune ageing.

Is thymulin FDA-approved?

No. Thymulin is not approved by the FDA for any use. No human trial has established a dose, and preclinical doses do not translate to people.

Do genetics affect thymulin?

HLA, IL6 and FOXO3 variants are linked to immune and ageing traits, but none has been tested against thymulin levels or against response to thymulin.

This article is for informational and educational purposes only. It reports what published research found; it is not medical advice, it does not diagnose, treat, cure or prevent any disease, and nothing in it is a dose or a recommendation to use any compound. Talk to a licensed clinician about any medical decision.

Keep reading

Related articles

Peptide GuidesEpithalon and telomere length: what 30 years of research shows, and what it does not10 min readPeptide GuidesThymosin alpha-1: what 30 trials and a failed sepsis study actually showed10 min readPeptide GuidesCortagen peptide: 5 things most articles get wrong9 min read
← PreviousRetatrutide: what the phase 3 trials found, and why it is not approvedPeptide Guides · 9 min readNext →Pinealon peptide: what the Russian research actually showsPeptide Guides · 9 min read
Upload your DNA